Skip to main content
Skip to navigation

Michael Garcia

Associate Professor of Biological Sciences
PhD, 1999 Mayo Clinic College of Medicine

Email: garciaml@missouri.edu
Office: 340C Christopher S. Bond Life Sciences Center
Phone: 573-882-9712
Additional: Website
Headshot of Michael Garcia

Research

Research summary

Molecular and cellular control of nerve development and disease

Research description

Transmission electron micrograph of an axon isolated from the 5th lumbar ventral root of an adult mouse. This image shows the transition from compact myelin (on left) to node of Ranvier. The paranodal loops indicate the end of the compact myelin and the beginning of the node of Ranvier. Within the axon, both neurofilaments and microtubules are visible.

Transmission electron micrograph of an axon isolated from the 5th lumbar ventral root of an adult mouse. This image shows the transition from compact myelin (on left) to node of Ranvier. The paranodal loops indicate the end of the compact myelin and the beginning of the node of Ranvier. Within the axon, both neurofilaments and microtubules are visible.

Specification of axonal diameter is a key component of motor system development and functioning, as axonal diameter is major axonal property that specifies the velocity of electrical signal conduction in the nervous system.

The diameter of myelinated axonal segments (internodes) is increased relative to the diameter of unmyelinated axonal segments (Nodes of Ranvier). Compare the diameter of the left side of the axon in the EM to the diameter on the right side of the image. Formation of compact myelin and axonal accumulation of neurofilaments are both required for axonal diameter specification. However, it is unclear how axons and myelinating cells interact to determine axonal diameter. One proposed mechanism is that myelinating cells signal the axon resulting in alterations to the neurofilament network that support radial growth of the axon.

We are, also interested in the pathogenesis of neurodegenerative diseases such as Charcot-Marie-Tooth (CMT), amyotrophic lateral sclerosis (Lou Gehrig's Disease) and spinal muscular atrophy.

We generate genetically modified mice to investigate the role of the neurofilament network in establishing axonal diameter and to determine the mechanisms of disease pathogenesis in CMT2E.

Select Publications

Select Publications

Hodgkinson, V.L., Dale, J.M., Garcia, M.L., Weisman, G.A., Lee, J., Gitlin, J.D., Petris, M.J., 2015. X-linked spinal muscular atrophy in mice caused by autonomous loss of ATP7A in the motor neuron. Journal of Pathology, 236:241-250.

Wortman, J.C., Shrestha, U.M., Barry, D.M., Garcia, M.L., Gross, S.P., Yu, C.C. (2014) Axonal transport: How high microtubule density can compensate for boundary effects. Biophysical Journal, 106: 813-823. PMCID: PMC3944719

Garcia, V.B., Garcia, M.L., Schulz, D.J., 2014. Quantitative expression profiling in mouse spinal cord reveals changing relationships among channel and receptor mRNA levels across postnatal maturation. Neuroscience, 277:21-333.

Cobb MS, Rose FF, Rindt H, Glascock JJ, Shababi M, Miller MR, Osman EY, Yen PF, Garcia ML, Martin BR, Wetz MJ, Mazzasette C, Feng Z, Ko CP, Lorson CL. (2013) Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy. Human Molecular Genetics, 22: 1843-1855

Barry, D.M., Stevenson, W., Bober, B.G., Wiese, P.J., Dale, J.M., Barry, G.S., Byers, N.S., Strope, J.D., Chang, R., Schulz, D.J., Shah, S., Calcutt, N.A., Gebremichael, Y., Garcia, M.L. (2012) Expansion of NF-M c terminus increases axonal diameter independent of increases in conduction velocity or myelin thickness. The Journal of Neuroscience, 32: 6209-6219.

Dale, J.M. and Garcia, M.L. (2012) Neurofilament phosphorylation in development and disease: Which came first the phosphorylation or the accumulation? Journal of Amino Acids. Article ID 382107

Dale, J.M., Villalón, E., Shannon, S.S., Barry, D.M., Markey, R.M., Garcia, V.B., Garcia, M.L. (2012) Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E. Genes, Brain and Behavior, 11: 360-365. PMCID: PMC3319473

Rindt, H., Buckley, D.M., Vale, S.M., Krogman, M., Rose, F.F., Garcia, M.L., Lorson, C.L. (2012) Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy. Neuromuscular Disorders, 22: 277-285. PMID: 22079083

Shen, H., Barry, D.M., Dale, J.M., Garcia, V.B., Calcutt, N.A., Garcia, M.L. (2011) Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E. Human Molecular Genetics, 20: 2535-2548. PMID: 21493625

Dale, J.M., Shen, H., Barry, D.M., Garcia, V.B., Rose, F.F., Lorson, C.L., Garcia, M.L. (2011) Altered axonal transport independent of global neurofilament alterations in SMAD7 mice. Acta Neuropathologica, 122: 331-341. PMID: 21681521

Shen, H.*, Barry, D.M.*, Garcia, M.L. (2010) Distal to proximal development of peripheral nerves requires the expression of neurofilament heavy. Neuroscience, 170: 16-21. PMCID: PMC2906171 *, Authors Contributed Equally.

Barry, D.M., Carpenter, C., Yager, C., Golik, B., Barry, K.J., Shen, H., Mikse, O., Eggert, L.S., Schulz, D.J., Garcia, M.L. (2010) Variation of the Neurofilament Medium KSP RepeatSub-domain across Mammalian Species: Implications for Altering Axonal Structure. Journal of ExperimentalBiology, 213: 128-136. PMID: 20008369